MiCareo Rare Cell Diagnostics
Unlocking the Secrets of Rare Cell.
SelectChip (microfluidic chip)
MiSelect R Platform
MiCareo focus on precision medicine and liquid biopsy technology for single rare cell isolation, such as circulating tumor cell and tumor-related rare immune cell. With a single device and from a single tube of whole blood, MiCareo’s technology can isolate and profile a single live cell, which can deliver both biological and genomic information. Our system is not only capable of characterizing for up to 13 biomarkers analysis with integrated staining and imaging, but also achieving single cell retrieval for downstream analysis.
Our all-in-one, fully automated MiSelect R System starts with whole blood and requires only 5 minutes hands-on time. This minimal sample prep enables better than 90% recovery efficiency with less than 10% variation in results across operators. The application of MiCareo's technology include enumeration of CTCs to monitor drug response, immune cell subtyping to discover their importance in IO treatments, and high purity cells isolation for single cell analysis.
- Type of business: Manufacturer
- Founding year: 2010
- Employee count (März 2019): 11-50
Your web browser is outdated. Update your browser for more security, speed and optimal presentation of this page.Update Browser